Anthony Vocat

MSc in Life Science, Medical Microbiology and Parasitology, in collaboration between Novartis and the University of Neuchâtel (magna cum laude).

Anthony has been working as a microbiologist for eight years and used multidisciplinary techniques to fight against infectious diseases with global impacts, such as tuberculosis and leprosy.

With very strong experience of handling dangerous microorganisms (bacteria, fungus and virus), he is licensed in class 1, 2 and 3 biosafety level laboratories. Study director of several preclinical and clinical projects (phase I and II), he was particularly involved in the discovery and development of a new antituberculosis drug called “Macozinone”.

Active participant of multiple European consortium of infectious diseases, he successfully generated data, wrote reports and brilliantly presented and discussed data in front of a massive audience.

Anthony is passionate about sports and plays football and floorball in official teams. For a touch of adrenaline and freedom, he likes to escape on his motorcycle.